Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Read more about Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response.
Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib. Read more about Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.
Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Read more about Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.
Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level. Read more about Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.
The first international workshop on the epigenetics of osteoarthritis. Read more about The first international workshop on the epigenetics of osteoarthritis.
SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling. Read more about SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.
Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain. Read more about Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain.
Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop. Read more about Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop.
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2. Read more about Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. Read more about EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
